Myths vs facts: VDR and Wechseljahre

The question of myths vs. facts regarding VDR (vitamin D receptor) and menopause requires careful distinction. A common myth is that specific VDR variants directly determine the severity of menopausal symptoms. While some studies have explored associations between VDR polymorphisms (e.g., FokI, BsmI, TaqI) and outcomes like bone density, mood, or hot flashes, the evidence is weak, inconsistent, and often based on small sample sizes. Menopause is primarily driven by the decline in estrogen production, not by VDR genetics. Another myth is that vitamin D supplementation tailored to one's VDR genotype can significantly alter menopause progression. Current data do not support such personalized recommendations. The fact is that vitamin D is essential for bone health and immune function, and deficiency should be corrected regardless of VDR genotype. Claims that VDR testing can predict menopause trajectory are not scientifically substantiated. Clinically, lifestyle factors, hormone status, and routine screening are far more relevant. In summary, VDR polymorphisms remain a research topic with limited translational value for menopause management.